Focus Partners Wealth
PDSB icon

Focus Partners Wealth’s PDS Biotechnology PDSB Stock Holding History

Focus Partners Wealth’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$414K Sell
551,759
-90,418
-14% -$51.4K ﹤0.01% 2121
2026
Q2 		$566K Buy
+642,177
New +$682K ﹤0.01% 1909

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Militia Capital Management
Militia Capital Management Austin, Texas $4B AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $106B AUM 29.93% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Focus Partners Wealth's PDSB Position: Q3 2026 in Review

Focus Partners Wealth reduced its PDS Biotechnology (PDSB) stake by 14% in Q3 2026, selling an estimated $51.4K and leaving 551,759 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

Focus Partners Wealth first reported a position in PDSB in Q2 2026 and has held it in 2 quarters since. The position peaked at $566K in Q2 2026. 48 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.

  • Focus Partners Wealth held 551,759 shares of PDS Biotechnology worth $414K as of Q3 2026.
  • Focus Partners Wealth sold 90,418 PDS Biotechnology shares in Q3 2026, an estimated $51.4K.
  • PDS Biotechnology made up ﹤0.01% of Focus Partners Wealth's portfolio in Q3 2026, its #2121 holding.
  • Focus Partners Wealth first reported a position in PDS Biotechnology in Q2 2026 and has held it in 2 quarters since.
  • Focus Partners Wealth's PDS Biotechnology position peaked at $566K in Q2 2026.
  • 48 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.

Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.